Show Causal, Unspecified relationship.

Disease

Query examples : disease : stomach cancer, breast cancer, heart disease, Cholangiocarcinoma, cardiac hypertrophy, etc (fuzzy search)

 

Disease
Detail
hsa-miR-107
Unspecified
Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma.
2008
hsa-miR-103
Unspecified
Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma.
2008
hsa-miR-203
Unspecified
MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival
2009
hsa-miR-375
Unspecified
MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival
2009
hsa-miR-192
Unspecified
MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival
2009
hsa-miR-194
Unspecified
MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival
2009
hsa-miR-21
Unspecified
MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival
2009
hsa-miR-223
Unspecified
MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival
2009
hsa-miR-205
Unspecified
MicroRNA expression profiles of esophageal cancer.
2008
hsa-miR-21
Unspecified
MicroRNA expression profiles of esophageal cancer.
2008
hsa-miR-203
Unspecified
MicroRNA expression profiles of esophageal cancer.
2008
hsa-miR-196a
Causal
MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
2008
hsa-miR-21
Causal
MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma.
2009
hsa-miR-196a
Causal
MicroRNA-196a is a Potential Marker of Progression during Barrett's Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus.
2009
hsa-miR-373
Causal
MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.
2009

 

Click here to get back to homepage.